Comment from Perrigo Company

Summary: Perrigo Company is seeking technical clarifications regarding specific sections of the draft guidance on the Common Technical Document for the Registration of Pharmaceuticals for Human Use. They request more precise language regarding Drug Master File references, reference standard requirements, "if applicable" qualifiers for certain justifications, and the definition of "reference country" in reliance procedures.